Improving Wound Care through Optimal Debridement

Web-based Modules

Sponsored by North American Center for Continuing Medical Education, LLC

Course Chair

John Lantis, MD
Chief, Division of Vascular and Endovascular Surgery
St Luke's - Roosevelt Hospital Center
Department of Surgery
New York, New York

Target Audience

This activity is designed for physicians, podiatrists, pharmacists, nurses, and others who treat patients with wounds.

Learning Objectives

After completing this activity, participants should be able to:

• Define the spectrum of debridement modalities and their appropriate selection based on wound characteristics
• Summarize the Wound Healing Society guideline recommendations for debridement
• Explain the potential roles of maintenance debridement and combination therapy with multiple debridement modalities
• Outline the benefits, limitations, and mechanism of action of available agents for enzymatic debridement

Activity Overview

This activity is an on-demand Web module. To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit.

Release Date: May 21, 2010

Expiration Date: May 21, 2011  

Estimated time to complete: 1 hour

There is no fee associated with this activity.

For questions regarding this educational activity, please call 609-371-1137.

This educational activity is a knowledge-based activity.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape or Safari browser. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.

This program is approved for 1 continuing education contact hour or 0.1 CEU.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-10-008-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.

CNE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity was approved for 1 contact hour. 

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1 contact hour.

Independent Clinical Reviewer: John Macdonald, MD, FACS, University of Miami, Department of Dermatology and Cutaneous Surgery, Fort Lauderdale, Florida

Nurse Reviewer: Judith LaJoie, RNC, CDE, CWS, ACHRN, DAPWCA, FCCWS, Associate Director of Nursing, New York Methodist Hospital, Brooklyn, New York

Planning Committee

The planning committee comprises John Lantis, MD; Judith LaJoie, RNC, CDE, CWS, ACHRN, DAPWCA, FCCWS; John Macdonald, MD, FACS; Emilie McCardell, Tiffney Oliver, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Lantis: Grant/Research Support—Healthpoint, Ark Therapeutics, Medline, Sanofi-Aventis; Consultant—Smith, Nephew, Nitric Bio, Macrocure; Promotional Speakers’ Bureau—Smith, Nephew, Healthpoint, KCI, Systagenix; Scientific Advisor—Nitric Bio
Dr. Macdonald: Promotional Speakers’ Bureau—3M; Consultant—3M
Ms. LaJoie has disclosed no relevant financial relationships with any commercial interests.

Ms. McCardell, Ms Oliver, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

The faculty have disclosed that the off-label use of small-intestine submucosa with negative pressure therapy will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2010 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from Healthpoint, Ltd.